申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US04418071A1
公开(公告)日:1983-11-29
The use of novel imidazolecarboxylic acid derivatives of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics ##STR1## wherein Q and T are an oxygen or sulfur atom; R is hydrogen, lower alkyl, lower alkylcarbonyl or benzoyl; R.sub.1 is hydrogen or --CH(R.sub.3)R.sub.4 ; R2 is lower alkoxy, phenoxy or phenoxy substituted at the ortho, meta, or para position with lower alkyl, lower alkoxy, hydroxy, halogen, trifluoromethyl, lower alkylthio, lower alkylsulfone, or lower alkylsulfoxide; R.sub.3 is hydrogen or lower alkyl; R.sub.4 is hydrogen, hydroxy, lower alkoxy, lower alkylcarbonyl, --ONO.sub.2 or halogen; and their pharmaceutically acceptable salts thereof.
以下是翻译结果:
具有以下一般结构的新型咪唑羧酸衍生物的使用,这些衍生物可用作降压药、心力衰竭药和抗血栓药,其中Q和T为氧或硫原子;R为氢、较低烷基、较低烷基羰基或苯甲酰基;R.sub.1为氢或--CH(R.sub.3)R.sub.4;R2为较低烷氧基、苯氧基或在邻位、间位或对位用较低烷基、较低烷氧基、羟基、卤素、三氟甲基、较低烷基硫基、较低烷基砜基或较低烷基亚砜基取代的苯氧基;R.sub.3为氢或较低烷基;R.sub.4为氢、羟基、较低烷氧基、较低烷基羰基、--ONO.sub.2或卤素;以及它们的药用盐。